With 3.59 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.47 million shares. The 52-week range on GENI shows that it touched its highest point at $10.33 and its lowest point at $4.91 during that stretch. It currently has a 1-year price target of $12.21. Beta for the stock currently stands at 2.08.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GENI was up-trending over the past week, with a rise of 10.82%, but this was up by 0.33% over a month. Three-month performance dropped to -7.34% while six-month performance rose 25.27%. The stock gained 38.02% in the past year, while it has gained 6.59% so far this year. A look at the trailing 12-month EPS for GENI yields -0.28 with Next year EPS estimates of 0.16. For the next quarter, that number is -0.04. This implies an EPS growth rate of 111.06% for this year and 444.45% for next year.
Float and Shares Shorts:
At present, 211.16 million GENI shares are outstanding with a float of 206.12 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GENI since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.13366 being high and -$0.14409 being low. For GENI, this leads to a yearly average estimate of -$0.14082. Based on analyst estimates, the high estimate for the next quarter is -$0.02 and the low estimate is -$0.02. The average estimate for the next quarter is thus -$0.02.
